research communications\(\def\hfill{\hskip 5em}\def\hfil{\hskip 3em}\def\eqno#1{\hfil {#1}}\)

Journal logoSTRUCTURAL BIOLOGY
COMMUNICATIONS
ISSN: 2053-230X

Structures of Mycobacterium tuberculosis isoprenyl diphosphate synthase Rv2173 in substrate-bound forms

crossmark logo

aBiomolecular Interaction Centre and School of Physical and Chemical Sciences, University of Canterbury. Christchurch, New Zealand, bSchool of Biological Sciences, University of Auckland, Auckland, New Zealand, and cSC Johnson & Son, 1525 Howe Street, Racine, WI 53403, USA
*Correspondence e-mail: timothy.allison@canterbury.ac.nz, jodie.johnston@canterbury.ac.nz

Edited by R. Sankaranarayanan, Centre for Cellular and Molecular Biology, Hyderabad, India (Received 21 January 2025; accepted 14 March 2025; online 1 April 2025)

We report structures of the Mycobacterium tuberculosis isoprenyl diphosphate synthase Rv2173 in three forms: apo and two substrate-bound forms [isoprenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP)]. The protein possesses a canonical all-α-helical trans-isoprenyl diphosphate synthase fold that is dimeric in each form. There are some differences between the structures: the IPP-bound form shows IPP bound in the DMAPP/allylic substrate-binding site with three divalent metal ions bound around the IPP and the complete C-terminus closing around the active site, while the apo and DMAPP-bound forms are more open, with some of the C-terminal region disordered, supporting suggestions that the C-terminus is important in substrate entry/product exit. In the DMAPP form DMAPP occupies the expected allylic substrate site, but only two metal ions are associated with the binding, with the DMAPP diphosphates adopting a slightly different binding pose compared with IPP in the same site, and the third metal-binding site is unoccupied. In no case is the IPP binding site occupied by IPP. There has been some uncertainty regarding product length for Rv2173, with variable lengths being reported. In the structures reported here, the `capping' residue at the bottom of the binding cavity is tryptophan and comparison with other IPP synthases suggests that the structure of Rv2173 is most consistent with a C10–C15 final product size.

1. Introduction

Polyisoprenyl diphosphates provide polyisoprenyl building blocks used in the biosynthesis of isoprenoid compounds such as steroids, chlorophyll, carotenoids and monoterpenes/diterpenes (Wang & Ohnuma, 2000[Wang, K. C. & Ohnuma, S. (2000). Biochim. Biophys. Acta, 1529, 33-48.]). These compounds have a wide range of lengths and varying stereochemistry at the double bonds (E/Z and all-E). Polyisoprenyl diphosphates are made via the sequential condensation of five-carbon iso­pentenyl diphosphate (IPP) units. The enzymes responsible for this condensation are known as prenyltransferases or isoprenyl diphosphate synthases (Ohnuma et al., 1996[Ohnuma, S., Narita, K., Nakazawa, T., Ishida, C., Takeuchi, Y., Ohto, C. & Nishino, T. (1996). J. Biol. Chem. 271, 30748-30754.]). Initial condensation involves the addition of IPP to its isomer dimethylallyldiphosphate (DMAPP) to form a product that can be further elongated by further condensation with additional IPP molecules (Ohnuma et al., 1996[Ohnuma, S., Narita, K., Nakazawa, T., Ishida, C., Takeuchi, Y., Ohto, C. & Nishino, T. (1996). J. Biol. Chem. 271, 30748-30754.]; Fig. 1[link]a). For the all-E enzymes this is believed to occur via a sequential ionization–condensation–elimination mechanism (Liang, 2009[Liang, P. H. (2009). Biochemistry, 48, 6562-6570.]). The allylic substrate (for example DMAPP or longer allylic substrates) is ionized to form a resonance-stabilized allylic cation, which is then attacked by the double bond of IPP. Elimination/double-bond formation of this condensed species is then mediated by proton abstraction by the diphosphate group formed during allylic substrate cleavage (Liang, 2009[Liang, P. H. (2009). Biochemistry, 48, 6562-6570.]; Christianson, 2017[Christianson, D. W. (2017). Chem. Rev. 117, 11570-11648.]). This can occur over several rounds, and the final product length depends on the specificity of the enzyme; all-E short-chain prenyltransferases make products of lengths C10–C25 [where C10 is geranyl diphosphate (GPP), C15 is farnesyl diphosphate (FPP), C20 is geranyl geranyl diphosphate (GGPP) etc.], while longer C30–C50 products are made by medium-chain or long-chain all-E-prenyltransferases (Wang & Ohnuma, 2000[Wang, K. C. & Ohnuma, S. (2000). Biochim. Biophys. Acta, 1529, 33-48.]; Ohnuma et al., 1996[Ohnuma, S., Narita, K., Nakazawa, T., Ishida, C., Takeuchi, Y., Ohto, C. & Nishino, T. (1996). J. Biol. Chem. 271, 30748-30754.]).

[Figure 1]
Figure 1
(a) IPP synthase reaction. (b) Rv2173 monomer (IPP-bound structure) with the core eight-helix bundle coloured blue and the additional helices in yellow. (c) Side (left) and top-down (right) views of the homodimer. Monomer 1 is coloured as in (b) and monomer 2 is in green with additional helices in orange. The metals from the IPP structure are shown as green spheres and the substrates IPP and DMAPP (from the superimposed DMAPP-bound structure) are shown as purple and pink sticks, respectively.

Two divalent-metal-binding aspartic acid-rich DDxxD motifs termed the FARM and SARM (first and second aspartic acid-rich DDxxD motifs) are important in all-E-prenyltransferase mechanisms (Park et al., 2012[Park, J., Lin, Y. S., De Schutter, J. W., Tsantrizos, Y. S. & Berghuis, A. M. (2012). BMC Struct. Biol. 12, 32.]; Christianson, 2017[Christianson, D. W. (2017). Chem. Rev. 117, 11570-11648.]; Chang et al., 2021[Chang, H.-Y., Cheng, T.-H. & Wang, A. H.-J. (2021). IUBMB Life, 73, 40-63.]). In head-to-tail condensations, the FARM and SARM sites collectively bind three metal ions (two to FARM and a third to the SARM), facilitating co­ordination of the diphosphate (PP) moiety of the allylic substrate (DMAPP or FPP/GPP etc.), which will be ionized (the head). The metal groups, coordinating to both the enzyme and substrate, are believed to both facilitate ionization/cation formation and retain the cleaved diphosphate in position for the later elimination steps (Christianson, 2017[Christianson, D. W. (2017). Chem. Rev. 117, 11570-11648.]; Liang, 2009[Liang, P. H. (2009). Biochemistry, 48, 6562-6570.]). In addition to the metals, further DMAPP–protein inter­actions are made through basic residues such as Arg and Lys (Chang et al., 2021[Chang, H.-Y., Cheng, T.-H. & Wang, A. H.-J. (2021). IUBMB Life, 73, 40-63.]; Park et al., 2012[Park, J., Lin, Y. S., De Schutter, J. W., Tsantrizos, Y. S. & Berghuis, A. M. (2012). BMC Struct. Biol. 12, 32.]). Binding of the allylic substrate to its binding site is thought to trigger a change in the enzyme from an open to a relatively closed conformation, helping to form the IPP binding site (the tail). Subsequent binding of IPP then facilitates the closure of the last four residues in the C-terminal tail over the active site (Park et al., 2012[Park, J., Lin, Y. S., De Schutter, J. W., Tsantrizos, Y. S. & Berghuis, A. M. (2012). BMC Struct. Biol. 12, 32.], 2017[Park, J., Zielinski, M., Magder, A., Tsantrizos, Y. S. & Berghuis, A. M. (2017). Nat. Commun. 8, 14132.]). Active-site closure is important to the formation and protection of reactive species such as the allylic carbocation during condensation (Christianson, 2017[Christianson, D. W. (2017). Chem. Rev. 117, 11570-11648.]). However, the closed active site must then open to allow release of the PPi leaving group from the allylic/DMAPP site and to allow the elongated product to either leave the IPP site or be transferred back to the allylic/DMAPP site ready for another round of elongation (Park et al., 2017[Park, J., Zielinski, M., Magder, A., Tsantrizos, Y. S. & Berghuis, A. M. (2017). Nat. Commun. 8, 14132.]).

Rv2173 has been identified as one of five E-isoprenyl diphosphate synthases (Rv0989c, Rv2173, Rv3383c, Rv0562 and Rv3398c) within Mycobacterium tuberculosis (Mann et al., 2011[Mann, F. M., Thomas, J. A. & Peters, R. J. (2011). FEBS Lett. 585, 549-554.]). Each enzyme can accommodate different starting allylic substrates and produce different length products. It had been suggested that Rv0989c, with its unusual FARM and SARM motifs, is the main M. tuberculosis GPP (C10) synthase that uses DMAPP as a substrate (Mann et al., 2011[Mann, F. M., Thomas, J. A. & Peters, R. J. (2011). FEBS Lett. 585, 549-554.]; Nagel et al., 2018[Nagel, R., Thomas, J. A., Adekunle, F. A., Mann, F. M. & Peters, R. J. (2018). Molecules, 23, 2546.]). Meanwhile, Rv0562 accepts a GPP starting substrate and produces a longer chain (C45) product that is likely to be used in menaquinone biosynthesis (Abe et al., 2020[Abe, T., Ozaki, S., Ueda, D. & Sato, T. (2020). ChemBioChem, 21, 2931-2938. ]). Rv3398c has been annotated as a FPP (C15) synthase that is limited to accepting GPP substrates (Dhiman et al., 2004[Dhiman, R. K., Schulbach, M. C., Mahapatra, S., Baulard, A. R., Vissa, V., Brennan, P. J. & Crick, D. C. (2004). J. Lipid Res. 45, 1140-1147.]), while Rv3383c is a GPP (C20) synthase that is limited to accepting FPP substrates (Mann et al., 2012[Mann, F. M., Xu, M., Davenport, E. K. & Peters, R. J. (2012). Front. Microbiol. 3, 368.]). Functional studies have suggested that Rv2173 is versatile, capable of producing variable chain-length products from DMAPP, including products as long as GGPP (C20), although the enzymatic activity was episodic (Mann et al., 2012[Mann, F. M., Xu, M., Davenport, E. K. & Peters, R. J. (2012). Front. Microbiol. 3, 368.]). Product length determination is guided by the FARM and SARM motifs (Nagel et al., 2018[Nagel, R., Thomas, J. A., Adekunle, F. A., Mann, F. M. & Peters, R. J. (2018). Molecules, 23, 2546.]), with the size of the fifth residue before the FARM being associated with determining the chain length and larger residues limiting the size of the binding pocket (Ohnuma et al., 1996[Ohnuma, S., Narita, K., Nakazawa, T., Ishida, C., Takeuchi, Y., Ohto, C. & Nishino, T. (1996). J. Biol. Chem. 271, 30748-30754.]). For Rv2173, this fifth residue is a tryptophan, suggesting that Rv2173 will produce a short-chain product. The exact functional role of Rv2173 in the cell is uncertain, although recent research appears to confirm a shorter product length, annotating Rv2173 as an E-C10–15 synthase and giving it a newly proposed biological function in the biosynthesis of glycosyl carrier lipids (Abe et al., 2020[Abe, T., Ozaki, S., Ueda, D. & Sato, T. (2020). ChemBioChem, 21, 2931-2938. ]). This annotation is hinted at by its genomic location immediately downstream of a putative α(1→6)-mannopyranosyltransferase (MptA, Rv2174) involved in lipomannan biosynthesis (Mishra et al., 2011[Mishra, A. K., Driessen, N. N., Appelmelk, B. J. & Besra, G. S. (2011). FEMS Microbiol. Rev. 35, 1126-1157.]). This ability of Rv2173 to produce shorter products, including GPP, is also purported to facilitate functional redundancy within the bacterium, explaining for example why Rv0989c is not essential in knockout studies (Abe et al., 2020[Abe, T., Ozaki, S., Ueda, D. & Sato, T. (2020). ChemBioChem, 21, 2931-2938. ]).

2. Materials and methods

2.1. Macromolecule production

M. tuberculosis Rv2173 was expressed using a pDEST-17-based plasmid vector obtained from Dr Mann and coworkers containing an N-terminal 6×His tag (Table 1[link]; Mann et al., 2011[Mann, F. M., Thomas, J. A. & Peters, R. J. (2011). FEBS Lett. 585, 549-554.], 2012[Mann, F. M., Xu, M., Davenport, E. K. & Peters, R. J. (2012). Front. Microbiol. 3, 368.]). Purified pDEST-17-Rv2173 plasmid was transformed into chemically competent Escherichia coli BL21(DE3) or C41(DE3) cells for protein expression, with 100 µg ml−1 ampicillin used for selection (Table 1[link]). Small overnight cultures (5 ml) in MDG medium (Studier, 2005[Studier, F. W. (2005). Protein Expr. Purif. 41, 207-234.]) were used to inoculate 750 ml cultures in ZYM-5052 autoinduction medium (Studier, 2005[Studier, F. W. (2005). Protein Expr. Purif. 41, 207-234.]). The cultures were grown at 37°C for 3 h followed by 18°C for ∼16 h, with shaking at 300 rev min−1. Other batches were grown using fermentation; a 100 ml overnight culture in MDG medium was used to inoculate 10 l ZYM-5052 medium in a 19.5 l fermenter (New Brunswick Scientific). The fermentative cultures were grown similarly to the flask-based cultures. The cells were harvested by centrifugation at 5000g for 30 min at 4°C and the cell pellets were stored at −80°C until use.

Table 1
Macromolecule-production information

Source organism Mycobacterium tuberculosis
DNA source Genomic DNA
Expression vector pDEST-17
Expression host Escherichia coli BL21(DE3) and C41(DE3)
Complete amino-acid sequence of the construct produced MSYYHHHHHHLESTSLYKKAGSAAALFRFKKEPFTMAGAITDQLRRYLHGRRRAAAHMGSDYDGLIADLEDFVLGGGKRLRPLFAYWGWHAVASREPDPDVLLLFSALELLHAWALVHDDLIDRSATRRGRPTAQLRYAALHRDRDWRGSPDQFGMSAAILLGDLAQVWADDIVSKVCQSALAPDAQRRVHRVWADIRNEVLGGQYLDIVAEASAAESIESAMNVATLKTACYTVSRPLQLGTAAAADRSDVAAIFEHFGADLGVAFQLRDDVLGVFGDPAVTGKPSGDDLKSGKRTVLVAEAVELADRSDPLAAKLLRTSIGTRLTDAQVRELRTVIEAVGARAAAESRIAALTQRALATLASAPINATAKAGLSELAMMAANRSA

The cell pellets were resuspended in lysis buffer [for the apo and IPP crystals this was 50 mM Tris–HCl pH 7.0, 150 mM NaCl, 5%(v/v) glycerol and either 1 mM tris(2-carboxyethyl)phosphine (TCEP) or 1 mM β-mercaptoethanol; for the DMAPP-bound crystals the buffer composition was 50 mM HEPES pH 8.0, 5 mM MgCl2, 500 mM NaCl, 20 mM imidazole, 1 mM TCEP] containing a cOmplete Mini EDTA-free protease-inhibitor cocktail tablet. The resuspended cells were lysed by cell disruption using a Microfluidics cell disruptor at 124 MPa (Newton, USA). Following clarification (20 000g, 30 min, 4°C), the supernatant liquid was filtered (0.45 µm and then 0.22 µm) and purified by immobilized-metal affinity chromatography (IMAC) using a 5 ml HisTrap HP column (Cytiva). Rv2173 was eluted from the column using a gradient of elution buffer (the same as lysis buffer but containing 500 mM imidazole). For the protein used to create the apo and IPP crystals, further purification was performed by size-exclusion chromatography using a Superdex 200 10/300 GL column [50 mM Tris pH 7, 150 mM NaCl, 5%(v/v) glycerol]. Purified protein was stored at 4°C, or for longer-term storage at −80°C, until use.

2.2. Crystallization

Due to limited solubility, the tagged Rv2173 could only be concentrated to 0.7–2.2 mg ml−1. Crystallization-condition screening was carried out using a Cartesian robotic system with a 480-component screen (Moreland et al., 2005[Moreland, N., Ashton, R., Baker, H. M., Ivanovic, I., Patterson, S., Arcus, V. L., Baker, E. N. & Lott, J. S. (2005). Acta Cryst. D61, 1378-1385.]) and the commercial MORPHEUS screen (Gorrec, 2009[Gorrec, F. (2009). J. Appl. Cryst. 42, 1035-1042.]). Optimization of the most promising crystallization conditions was performed in 24-well hanging-drop plates, with successful crystallization in 1:1, 2:1 and 3:1 protein:reservoir solution ratios. IPP-bound and DMAPP-bound crystals were grown from co-crystallization experiments with the substrate (5–9 mM) added to the protein solution immediately prior to crystallization (Table 2[link]). The crystals were harvested and then either immediately flash-cooled in liquid nitrogen (apo and DMAPP crystals) or soaked in cryoprotectant [well solution plus 25%(v/v) glycerol] and then flash-cooled.

Table 2
Crystallization

  Apo IPP-bound DMAP-bound
Method Vapour diffusion
Plate type 96-well sitting drop and 24-well hanging drop
Temperature (K) 291
Protein concentration (mg ml−1) 0.7–2.2
Buffer composition of protein solution 50 mM Tris pH 7, 150 mM NaCl, 5%(v/v) glycerol, 1 mM TCEP or β-mercaptoethanol 50 mM Tris pH 7, 150 mM NaCl, 5%(v/v) glycerol, 1 mM TCEP or β-mercaptoethanol, 5 mM IPP 50 mM HEPES pH 8.0, 5 mM MgCl2, 500 mM NaCl, 200–250 mM imidazole, 1 mM TCEP, 9 mM DMAPP
Composition of reservoir solution 0.1 M Bicine–Tris pH 8.5, 10% PEG 4000, 24% glycerol, 0.03 M DC mix CaCl2 and MgCl2 0.1 M Tris pH 7.5, 0.2 M calcium acetate, 20% PEG 3350 0.1 M Bicine–Tris pH 8.3, 12.5% PEG 4K, 25% glycerol, 0.03 M CA mix CaCl2 and MgCl2
Volume and ratio of drop 1–4 µl total volume; protein:well ratios 1:1, 2:1, 3:1
Volume of reservoir (µl) 500–600

2.3. Data collection and processing

Diffraction data were collected on the MX2 macromolecular crystallography beamline at the Australian Synchrotron (Aragão et al., 2018[Aragão, D., Aishima, J., Cherukuvada, H., Clarken, R., Clift, M., Cowieson, N. P., Ericsson, D. J., Gee, C. L., Macedo, S., Mudie, N., Panjikar, S., Price, J. R., Riboldi-Tunnicliffe, A., Rostan, R., Williamson, R. & Caradoc-Davies, T. T. (2018). J. Synchrotron Rad. 25, 885-891.]) equipped with an ADSC Quantum 315r CCD detector (Meyer et al., 2014[Meyer, G. R., Aragão, D., Mudie, N. J., Caradoc-Davies, T. T., McGowan, S., Bertling, P. J., Groenewegen, D., Quenette, S. M., Bond, C. S., Buckle, A. M. & Androulakis, S. (2014). Acta Cryst. D70, 2510-2519.]). All data sets were processed and scaled with XDS (Kabsch, 2010a[Kabsch, W. (2010a). Acta Cryst. D66, 125-132.],b[Kabsch, W. (2010b). Acta Cryst. D66, 133-144.]) and merged with AIMLESS (Evans & Murshudov, 2013[Evans, P. R. & Murshudov, G. N. (2013). Acta Cryst. D69, 1204-1214.]). The most likely space group, P21212 or I222, was determined using POINTLESS from the CCP4 suite (Agirre et al., 2023[Agirre, J., Atanasova, M., Bagdonas, H., Ballard, C. B., Baslé, A., Beilsten-Edmands, J., Borges, R. J., Brown, D. G., Burgos-Mármol, J. J., Berrisford, J. M., Bond, P. S., Caballero, I., Catapano, L., Chojnowski, G., Cook, A. G., Cowtan, K. D., Croll, T. I., Debreczeni, J. É., Devenish, N. E., Dodson, E. J., Drevon, T. R., Emsley, P., Evans, G., Evans, P. R., Fando, M., Foadi, J., Fuentes-Montero, L., Garman, E. F., Gerstel, M., Gildea, R. J., Hatti, K., Hekkelman, M. L., Heuser, P., Hoh, S. W., Hough, M. A., Jenkins, H. T., Jiménez, E., Joosten, R. P., Keegan, R. M., Keep, N., Krissinel, E. B., Kolenko, P., Kovalevskiy, O., Lamzin, V. S., Lawson, D. M., Lebedev, A. A., Leslie, A. G. W., Lohkamp, B., Long, F., Malý, M., McCoy, A. J., McNicholas, S. J., Medina, A., Millán, C., Murray, J. W., Murshudov, G. N., Nicholls, R. A., Noble, M. E. M., Oeffner, R., Pannu, N. S., Parkhurst, J. M., Pearce, N., Pereira, J., Perrakis, A., Powell, H. R., Read, R. J., Rigden, D. J., Rochira, W., Sammito, M., Sánchez Rodríguez, F., Sheldrick, G. M., Shelley, K. L., Simkovic, F., Simpkin, A. J., Skubak, P., Sobolev, E., Steiner, R. A., Stevenson, K., Tews, I., Thomas, J. M. H., Thorn, A., Valls, J. T., Uski, V., Usón, I., Vagin, A., Velankar, S., Vollmar, M., Walden, H., Waterman, D., Wilson, K. S., Winn, M. D., Winter, G., Wojdyr, M. & Yamashita, K. (2023). Acta Cryst. D79, 449-461.]). An Rfree set corresponding to 5% of reflections was assigned. In the case of the apo crystal diffraction data, the twofold axis is along the shortest cell edge, which differs from the conventional assignment of the unit cell for P222 space groups and thus required swapping of the unit-cell axes. Data-processing statistics for the three PDB-deposited structures are reported in Table 3[link].

Table 3
Data collection and processing

Values in parentheses are for the outer resolution shell.

Structure Apo IPP-bound DMAPP-bound
PDB code 8f8f 8f8k 8f8l
Diffraction source MX2 beamline, Australian Synchrotron MX2 beamline, Australian Synchrotron MX2 beamline, Australian Synchrotron
Wavelength (Å) 0.953700 0.953700 0.953700
Space group P21212 I222 I222
a, b, c (Å) 81.80, 190.71, 66.48 65.66, 82.69, 189.38 66.54, 83.84, 188.12
α, β, γ (°) 90, 90, 90 90, 90, 90 90, 90, 90
Resolution range (Å) 19.76–2.00 (2.00–2.04) 19.80–2.20 (2.20–2.27) 19.58–2.20 (2.20–2.27)
No. of unique reflections 71090 (4495) 26593 (2255) 26527 (2016)
No. of observations 103648 (66769) 389059 (33239) 365883 (18434)
Multiplicity 14.6 (14.9) 14.6 (14.7) 13.8 (9.1)
Rmerge (all I−/I+) 0.124 (3.25) 0.187 (4.175) 0.229 (2.696)
Rp.i.m. (all I+/I−) 0.033 (0.865) 0.051 (1.124) 0.064 (0.923)
CC1/2 0.999 (0.384) 0.999 (0.359) 0.996 (0.238)
I/σ(I)〉 17.8 (1.2) 15.4 (0.9) 12.6 (0.9)
Completeness (%) 99.9 (100) 99.9 (100) 97.2 (82.0)
Wilson B factor (Å2) 38.84 45.52 35.71
†The mean I/σ(I) in the outer shell falls below 2.0 at resolutions above 2.11, 2.44 and 2.44 Å for the apo, IPP and DMAPP data sets, respectively. Analyses of merged CC1/2 correlations between intensity estimates from half-data sets (Karplus & Diederichs, 2015[Karplus, P. A. & Diederichs, K. (2015). Curr. Opin. Struct. Biol. 34, 60-68.]) were used to influence the high-resolution cutoff for data processing.

2.4. Structure solution and refinement

Matthews analysis (Matthews, 1968[Matthews, B. W. (1968). J. Mol. Biol. 33, 491-497.]; Kantardjieff & Rupp, 2003[Kantardjieff, K. A. & Rupp, B. (2003). Protein Sci. 12, 1865-1871.]) determined that there were likely to be two molecules in the asymmetric unit for P21212 structures and one for I222. Molecular replacement was completed using Phaser (McCoy et al., 2007[McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C. & Read, R. J. (2007). J. Appl. Cryst. 40, 658-674.]) using initial refined but unpublished Rv2173 models. After molecular replacement, iterative rounds of refinement in REFMAC5 (Vagin et al., 2004[Vagin, A. A., Steiner, R. A., Lebedev, A. A., Potterton, L., Mc­Nicholas, S., Long, F. & Murshudov, G. N. (2004). Acta Cryst. D60, 2184-2195.]) in CCP4 (Agirre et al., 2023[Agirre, J., Atanasova, M., Bagdonas, H., Ballard, C. B., Baslé, A., Beilsten-Edmands, J., Borges, R. J., Brown, D. G., Burgos-Mármol, J. J., Berrisford, J. M., Bond, P. S., Caballero, I., Catapano, L., Chojnowski, G., Cook, A. G., Cowtan, K. D., Croll, T. I., Debreczeni, J. É., Devenish, N. E., Dodson, E. J., Drevon, T. R., Emsley, P., Evans, G., Evans, P. R., Fando, M., Foadi, J., Fuentes-Montero, L., Garman, E. F., Gerstel, M., Gildea, R. J., Hatti, K., Hekkelman, M. L., Heuser, P., Hoh, S. W., Hough, M. A., Jenkins, H. T., Jiménez, E., Joosten, R. P., Keegan, R. M., Keep, N., Krissinel, E. B., Kolenko, P., Kovalevskiy, O., Lamzin, V. S., Lawson, D. M., Lebedev, A. A., Leslie, A. G. W., Lohkamp, B., Long, F., Malý, M., McCoy, A. J., McNicholas, S. J., Medina, A., Millán, C., Murray, J. W., Murshudov, G. N., Nicholls, R. A., Noble, M. E. M., Oeffner, R., Pannu, N. S., Parkhurst, J. M., Pearce, N., Pereira, J., Perrakis, A., Powell, H. R., Read, R. J., Rigden, D. J., Rochira, W., Sammito, M., Sánchez Rodríguez, F., Sheldrick, G. M., Shelley, K. L., Simkovic, F., Simpkin, A. J., Skubak, P., Sobolev, E., Steiner, R. A., Stevenson, K., Tews, I., Thomas, J. M. H., Thorn, A., Valls, J. T., Uski, V., Usón, I., Vagin, A., Velankar, S., Vollmar, M., Walden, H., Waterman, D., Wilson, K. S., Winn, M. D., Winter, G., Wojdyr, M. & Yamashita, K. (2023). Acta Cryst. D79, 449-461.]) or Phenix (Liebschner et al., 2019[Liebschner, D., Afonine, P. V., Baker, M. L., Bunkóczi, G., Chen, V. B., Croll, T. I., Hintze, B., Hung, L.-W., Jain, S., McCoy, A. J., Moriarty, N. W., Oeffner, R. D., Poon, B. K., Prisant, M. G., Read, R. J., Richardson, J. S., Richardson, D. C., Sammito, M. D., Sobolev, O. V., Stockwell, D. H., Terwilliger, T. C., Urzhumtsev, A. G., Videau, L. L., Williams, C. J. & Adams, P. D. (2019). Acta Cryst. D75, 861-877.]) were interspersed with rounds of model building in Coot (Emsley & Cowtan, 2004[Emsley, P. & Cowtan, K. (2004). Acta Cryst. D60, 2126-2132.]; Emsley et al., 2010[Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. (2010). Acta Cryst. D66, 486-501.]). Modelling of the metals as Ca2+ ions, based on the crystallization conditions, gave a better fit, minimizing the residual density compared with modelling as Mg2+, with similar B factors to those of other ligands. While Mg2+ is the assumed physiological ligand, accommodation of another metal is not unprecedented; Rv2173 activity has been tested by other groups with Mg2+, Mn2+ and Co2+, and it has been shown to be active with a similar product distribution (Abe et al., 2020[Abe, T., Ozaki, S., Ueda, D. & Sato, T. (2020). ChemBioChem, 21, 2931-2938. ]). In addition to the co-crystallized substrate components, several ligands (components of the crystallization condition or cryoprotectant conditions) were also modelled where appropriate. The refined final structures (Table 4[link]) were deposited in the PDB as entries 8f8f, 8f8k and 8f8l.

Table 4
Structure refinement

Structure Apo IPP-bound DMAPP-bound
PDB code 8f8f 8f8k 8f8l
Resolution range (Å) 19.76–2.00 (2.00–2.03) 19.80–2.20 (2.20–2.28) 19.58–2.20 (2.20–2.28)
Completeness (%) 99.98 99.94 97.22
σ Cutoff 1.34 1.34 1.34
No. of reflections
 Working set 67437 (2520) 25242 (2448) 25173 (2059)
 Test set 3577 (140) 1335 (148) 1336 (128)
Rwork 0.2121 (0.3807) 0.2083 (0.3782) 0.2108 (0.3213)
Rfree 0.2384 (0.4367) 0.2388 (0.4013) 0.2436 (0.3300)
No. of non-H atoms
 Total 5642 2806 2768
 Protein 5318 2668 2608
 Ligand 55 46 22
 Solvent 269 92 138
R.m.s. deviations
 Bond lengths (Å) 0.002 0.002 0.002
 Angles (°) 0.454 0.488 0.377
Average B factors (Å2)
 Protein 47.00 55.30 43.54
 Ligand 65.57 61.39 50.17
 Solvent 48.66 53.92 41.91
Ramachandran plot
 Most favoured (%) 99.42 98.29 99.42
 Allowed (%) 0.58 1.71 0.58

During the building and refinement of the initial unpublished models (see the supporting information for further details) generated from molecular replacement with lower resolution data using a BALBES-modified (Keegan et al., 2011[Keegan, R. M., Long, F., Fazio, V. J., Winn, M. D., Murshudov, G. N. & Vagin, A. A. (2011). Acta Cryst. D67, 313-323.]; Long et al., 2008[Long, F., Vagin, A. A., Young, P. & Murshudov, G. N. (2008). Acta Cryst. D64, 125-132.]) version of a geranylgeranyl pyrophosphate synthase from Corynebacterium glutamicum (PDB entry 3lk5; New York SGX Research Center for Structural Genomics, unpublished work; Supplementary Fig. S3), analysis using Zanuda (Lebedev & Isupov, 2014[Lebedev, A. A. & Isupov, M. N. (2014). Acta Cryst. D70, 2430-2443.]) helped to determine the correct axis for the twofold-symmetry element in the P21212 space group.

2.5. Native mass spectrometry

Nano-electrospray ionization tips, with an orifice diameter of approximately 1 µm, were fabricated from 1.0 mm outer diameter and 0.75 mm inner diameter thin-walled glass capillaries (World Precision Instruments) using a P-2000 Micropipette Puller (Sutter). Pulled tips were gold-coated using a Q150R Plus Rotary Pumped Coater (Quorum). Prior to analysis, the protein sample (0.2 mg ml−1) was buffer-exchanged into 0.75 M ammonium acetate using Micro Bio-Spin Chromatography Columns (Bio-Rad) and then centrifuged at 17 000g for 2 min before dispensing into an electrospray capillary. Experiments were performed on a Synapt XS High Resolution Mass Spectrometer. The capillary voltage was typically 0.8 kV and the instrument was tuned for the transmission and preservation of high-mass protein complexes.

3. Results and discussion

3.1. Rv2173 is a homodimer

Consistent with most E-prenyltransferases, which exist as homodimers or heterodimers (Chang et al., 2021[Chang, H.-Y., Cheng, T.-H. & Wang, A. H.-J. (2021). IUBMB Life, 73, 40-63.]), Rv2173 is a dimer in the crystal structure, with this biological assembly supported by native mass spectrometry (Supplementary Fig. S1). The apo structure was solved with a dimer in the asymmetric unit in space group P21212, while both substrate-bound structures were solved in space group I222 with monomers in the asymmetric unit, generating dimers on the application of crystallographic symmetry. PISA analysis shows that the interface buries ∼15% of solvent-accessible surface area with a CCS score of 0.752 (Krissinel & Henrick, 2007[Krissinel, E. & Henrick, K. (2007). J. Mol. Biol. 372, 774-797.]). The monomeric units of each homodimer are oriented in a parallel fashion, with the lid helices located on the same side, such that both active sites open on the same face (Fig. 1[link]c). This is a typical arrangement for homodimeric E-prenyltransferases, and it appears that dimer formation may be important in some of these enzymes for function via the creation of networks influencing the stability of substrate-binding sites (Chang et al., 2013[Chang, C.-K., Teng, K.-H., Lin, S.-W., Chang, T.-H. & Liang, P.-H. (2013). Biochemistry, 52, 2783-2792.]), while in others it may influence product cavity size (Artz et al., 2011[Artz, J. D., Wernimont, A. K., Dunford, J. E., Schapira, M., Dong, A., Zhao, Y., Lew, J., Russell, R. G., Ebetino, F. H., Oppermann, U. & Hui, R. (2011). J. Biol. Chem. 286, 3315-3322.]).

3.2. Rv2173 adopts a typical class I diterpene synthase fold

Rv2173 is folded as a decorated eight-helix bundle (Fig. 1[link]b), typical of the all-α-helical class I diterpene synthase fold (Supplementary Figs. S2–S4; Christianson, 2017[Christianson, D. W. (2017). Chem. Rev. 117, 11570-11648.]). Additional helices decorate the core fold to form a lid at the top of the active site and extensions involved in dimer interactions (Figs. 1[link]b and 1[link]c, Supplementary Figs. S2–S4). These lid helices have been implicated in controlled opening and closure of the active site during catalytic cycling, protecting the reactive species generated and allowing substrate binding/exchange and product exit (Sun et al., 2005[Sun, H.-Y., Ko, T.-P., Kuo, C.-J., Guo, R.-T., Chou, C.-C., Liang, P.-H. & Wang, A. H.-J. (2005). J. Bacteriol. 187, 8137-8148.]; Park et al., 2012[Park, J., Lin, Y. S., De Schutter, J. W., Tsantrizos, Y. S. & Berghuis, A. M. (2012). BMC Struct. Biol. 12, 32.]). The FARM and SARM motifs face each other from opposite helices of the substrate-binding cleft (Fig. 1[link]b; Supplementary Figs. S2–S4; Christianson, 2017[Christianson, D. W. (2017). Chem. Rev. 117, 11570-11648.]). All three structures are very similar (0.36–0.65 Å r.m.s.d. across all Cα atoms as calculated by SSM; Krissinel & Henrick, 2004[Krissinel, E. & Henrick, K. (2004). Acta Cryst. D60, 2256-2268.]), with the main variation being in the completeness of the C-terminus; the apo structure is missing the last four residues and the DMAPP-bound structure the last eight residues, while the IPP-bound structure has a complete C-terminus. It is these C-terminal residues in conjunction with the aforementioned lid helices that are likely to close the active site fully during the reaction cycle.

3.3. Active-site and C-terminal closure

The IPP-bound structure appears to be the most closed form with a fully ordered C-terminus. It has three metal ions bound: two to the FARM unit (DDLID; residues 84–88) and one near the SARM unit (DDVLGVFGD; residues 236–244), with the IPP occupying the putative allylic/DMAPP site, coordinating all three metal ions and making interactions with Lys194 and Lys260 (Fig. 2[link]b). While surprising, there is precedent for IPP binding to the allylic/DMAPP site in other E-prenyltransferases (Kavanagh, Dunford et al., 2006[Kavanagh, K. L., Dunford, J. E., Bunkoczi, G., Russell, R. G. G. & Oppermann, U. (2006). J. Biol. Chem. 281, 22004-22012.]; Kavanagh, Guo et al., 2006[Kavanagh, K. L., Guo, K., Dunford, J. E., Wu, X., Knapp, S., Ebetino, F. H., Rogers, M. J., Russell, R. G. & Oppermann, U. (2006). Proc. Natl Acad. Sci. USA, 103, 7829-7834.]; Guo et al., 2007[Guo, R.-T., Cao, R., Liang, P.-H., Ko, T.-P., Chang, T.-H., Hudock, M. P., Jeng, W.-Y., Chen, C. K.-M., Zhang, Y., Song, Y., Kuo, C.-J., Yin, F., Oldfield, E. & Wang, A. H.-J. (2007). Proc. Natl Acad. Sci. USA, 104, 10022-10027.]). Interestingly, the third metal ion does not make any direct interaction with the SARM Asp236 as might have been expected from other three-metal-bound E-prenyltransferase structures (for example PDB entry 4h5e; Park et al., 2012[Park, J., Lin, Y. S., De Schutter, J. W., Tsantrizos, Y. S. & Berghuis, A. M. (2012). BMC Struct. Biol. 12, 32.]). The significance of this variance in metal-ion placement seen in Rv2173 is uncertain, although it has been suggested all three metal ions are needed for successful carbocation formation as well as for retention of the cleaved diphosphate for its role in elimination (Christianson, 2017[Christianson, D. W. (2017). Chem. Rev. 117, 11570-11648.]). Variations in the FARM and SARM motifs have been proposed to influence how the metals coordinate (Artz et al., 2011[Artz, J. D., Wernimont, A. K., Dunford, J. E., Schapira, M., Dong, A., Zhao, Y., Lew, J., Russell, R. G., Ebetino, F. H., Oppermann, U. & Hui, R. (2011). J. Biol. Chem. 286, 3315-3322.]; Nagel et al., 2018[Nagel, R., Thomas, J. A., Adekunle, F. A., Mann, F. M. & Peters, R. J. (2018). Molecules, 23, 2546.]); however, it is important to note that IPP is not the physiological ligand for the metal-associated allylic binding site. Additionally, in all structures, and even in this most closed form, the basic residue Lys43, which is likely to be important for the binding of the PP group in the IPP site, is poorly ordered and this disorder may also influence variability in positioning of the metal ions.

[Figure 2]
Figure 2
(a) DMAPP binding into FARM in Rv2173. (b) IPP binding into FARM and SARM in Rv2173. (c) Overlay of the FARM and SARM allylic/DMAPP binding site in DMAPP-bound and IPP-bound structures. The DMAPP-bound structure is coloured light pink, with metal ions as green spheres and DMAPP as pink sticks. The IPP-bound structure is coloured blue, with metal ions as green spheres and the IPP and acetate as purple sticks. Waters are shown as red spheres and polar contacts as grey dashes. (d) Overlay of the IPP-bound (blue), DMAPP-bound (light pink) and apo (white) structures with a focus on the differences in the C-terminus leading to active-site closure.

The DMAPP-bound structure represents the most open form, with no electron density observed for the last eight residues from the C-terminus. Two metal ions bind to the FARM, coordinating to the DMAPP bound in the allylic/DMAPP site (Fig. 2[link]a). Notably, in other structural studies of related enzymes it is common for not all three metal ions to be observed (Guo et al., 2007[Guo, R.-T., Cao, R., Liang, P.-H., Ko, T.-P., Chang, T.-H., Hudock, M. P., Jeng, W.-Y., Chen, C. K.-M., Zhang, Y., Song, Y., Kuo, C.-J., Yin, F., Oldfield, E. & Wang, A. H.-J. (2007). Proc. Natl Acad. Sci. USA, 104, 10022-10027.]). Compared with IPP, the DMAPP diphosphate (PP) group appears to exhibit greater coordination to both FARM-site metal ions present, whereas in the IPP-bound structure IPP appears to be coordinated by just one of its phosphate groups (Figs. 2[link]a–2[link]c). This difference is consistent with the observation that the positioning of IPP and DMAPP in this site differs slightly (Fig. 2[link]c), with the binding mode observed for DMAPP best mirroring other complexes (for example various GGPP synthase complexes; Guo et al., 2007[Guo, R.-T., Cao, R., Liang, P.-H., Ko, T.-P., Chang, T.-H., Hudock, M. P., Jeng, W.-Y., Chen, C. K.-M., Zhang, Y., Song, Y., Kuo, C.-J., Yin, F., Oldfield, E. & Wang, A. H.-J. (2007). Proc. Natl Acad. Sci. USA, 104, 10022-10027.]).

Comparison to related enzyme structures with IPP sites occupied (for example PDB entries 2e8v, 2e8t and 2e8u; Guo et al., 2007[Guo, R.-T., Cao, R., Liang, P.-H., Ko, T.-P., Chang, T.-H., Hudock, M. P., Jeng, W.-Y., Chen, C. K.-M., Zhang, Y., Song, Y., Kuo, C.-J., Yin, F., Oldfield, E. & Wang, A. H.-J. (2007). Proc. Natl Acad. Sci. USA, 104, 10022-10027.]) has helped to identify the IPP binding site in Rv2173 (Lys43, Arg90, His77, Arg46, Thr195 and Phe232). While this putative binding site is never observed to be occupied by IPP, in the case of the IPP-bound structure an acetate artefact from the crystallization condition appears to occupy part of this site, although the site itself (for example Lys43) shows aspects of disorder consistent with its lack of substrate occupancy (Fig. 2[link]d). We observe a role for Phe232 from this site in changes associated with C-terminal closure in the IPP-bound structure. In this structure, Arg350 faces into the active site and forms hydrogen-bonding interactions with the final C-terminal residue Ala352, as well as Asp236 from the SARM motif and the backbone of Phe232 (Fig. 2[link]d). Compared with the apo and DMAPP-bound structures, there is notable movement of Phe232, the side chain of which moves inwards to face the active site, facilitating its closure (Fig. 2[link]d). Studies of closure mechanisms for FPP synthase (FPPS) propose a cascade of changes from IPP occupation to C-terminal closure (Park et al., 2012[Park, J., Lin, Y. S., De Schutter, J. W., Tsantrizos, Y. S. & Berghuis, A. M. (2012). BMC Struct. Biol. 12, 32.]). Although limited conservation suggests that this mechanism is unlikely to be fully preserved in Rv2173, these three residues (Arg350/FPPSArg351; Phe232/FPPSPhe239; Asp236/FPPSAsp243) are conserved, correlating with their potential shared importance.

3.4. Chain length of product

Prior functional studies on Rv2173 have been inconsistent, with some evidence that Rv2173 can, episodically at least, produce products as long as GGPP (C20; Mann et al., 2012[Mann, F. M., Xu, M., Davenport, E. K. & Peters, R. J. (2012). Front. Microbiol. 3, 368.]), although more recent research appears to suggest a shorter principal product, annotating Rv2173 as an E-C10–15 synthase (Abe et al., 2020[Abe, T., Ozaki, S., Ueda, D. & Sato, T. (2020). ChemBioChem, 21, 2931-2938. ]). We performed various soaking and co-crystallization experiments with potential substrates/products longer than C5, but no associated ligand density was observed. We therefore turned to analysis of the structure and sequence of Rv2173 to give insight into the most plausible maximal product length. The fifth residue pre-FARM in IPP synthases helps to determine the product length (Ohnuma et al., 1996[Ohnuma, S., Narita, K., Nakazawa, T., Ishida, C., Takeuchi, Y., Ohto, C. & Nishino, T. (1996). J. Biol. Chem. 271, 30748-30754.]; Feng et al., 2020[Feng, Y., Morgan, R. M. L., Fraser, P. D., Hellgardt, K. & Nixon, P. J. (2020). Front. Plant Sci. 11, 589.]). In Rv2173, this residue is a large bulky tryptophan (Trp79), suggesting relatively short products. However, the product-length determination can be more nuanced than a single residue, with some suggestions for CrtE (PDB entry 6sxl) that three `floors' of residues in the substrate-binding cleft are influential in determining product length; bulky residues in floor 1 limit the cavity size to a C15/FPP product, while access past this floor with bulky residues in floors 2 or 3 result in C20/GGPP and C25/GFPP products, respectively (Feng et al., 2020[Feng, Y., Morgan, R. M. L., Fraser, P. D., Hellgardt, K. & Nixon, P. J. (2020). Front. Plant Sci. 11, 589.]). The residues equivalent to floor 1 in Rv2173 are Trp79, Ala80 and Leu167, those equivalent to floor 2 are Gln132, Leu76 and Arg163, and those equivalent to floor 3 are Trp159, Ala72 and Asp136 (Fig. 3[link]), supporting the idea that Rv2173 produces shorter length products such as FPP. This proposition is further supported by comparison of Rv2173 with a GGPP synthase structure with longer chain substrate/product analogues (for example PDB entries 2e8v and 2e8t; Guo et al., 2007[Guo, R.-T., Cao, R., Liang, P.-H., Ko, T.-P., Chang, T.-H., Hudock, M. P., Jeng, W.-Y., Chen, C. K.-M., Zhang, Y., Song, Y., Kuo, C.-J., Yin, F., Oldfield, E. & Wang, A. H.-J. (2007). Proc. Natl Acad. Sci. USA, 104, 10022-10027.]), which appears to confirm that Trp79 and Leu167 will limit the pocket size, and another bulky residue, Tyr198, will block access to the bottom of the pocket (Fig. 3[link]). Together, these factors suggest that Rv2173 could best accommodate a final substrate the size of GPP, yielding a product the size of FPP and supporting the later functional annotation as a C10–C15 product-length synthase.

[Figure 3]
Figure 3
Product-length pocket and floors. (a) The three floors in Rv2173: floor 1 in light pink, floor 2 in orange and floor 3 in blue with Tyr198 in lime. (b) Close-up showing the floor residues as a surface. In both panels to mark the allylic DMAPP site, DMAPP is shown as magenta sticks, with metal ions as green spheres. The FPP (C15) bound in as the substrate in this site from a superposition with PDB entry 2e8t is shown in dark grey. The GGPP (C20) from PDB entry 2e8v as the product in the IPP site is shown as light grey sticks. GGPP comes into close contact with the floor residues, suggesting that a smaller size (C10 or C15) product would be preferred.

4. Conclusion

Rv2173 is a homodimer with a canonical class I diterpene synthase fold, with structural analysis identifying some conserved mechanistic features in C-terminal closure and supporting its annotation as a short-chain (C10–C15) product-length synthase.

5. Related literature

The following references are cited in the supporting information for this article: Bricogne et al. (2017[Bricogne, G., Blanc, E., Brandl, M., Flensburg, C., Keller, P., Paciorek, W., Roversi, P, Sharff, A., Smart, O. S., Vonrhein, C. & Womack, T. O. (2017). BUSTER version 2.10.0. Cambridge: Global Phasing Ltd.]), Evans (2006[Evans, P. (2006). Acta Cryst. D62, 72-82.]), Madeira et al. (2024[Madeira, F., Madhusoodanan, N., Lee, J., Eusebi, A., Niewielska, A., Tivey, A. R. N., Lopez, R. & Butcher, S. (2024). Nucleic Acids Res. 52, W521-W525.]) and Robert & Gouet (2014[Robert, X. & Gouet, P. (2014). Nucleic Acids Res. 42, W320-W324.]).

Supporting information


Acknowledgements

This research was undertaken in part using the MX2 beamline at the Australian Synchrotron, which is part of ANSTO. Access to the Australian Synchrotron was supported by the New Zealand Synchrotron Group Ltd. Open access publishing facilitated by University of Canterbury, as part of the Wiley–University of Canterbury agreement via the Council of Australian University Librarians.

Funding information

We acknowledge the following for funding support, in part: the Marsden Fund (contract UOC1901).

References

First citationAbe, T., Ozaki, S., Ueda, D. & Sato, T. (2020). ChemBioChem, 21, 2931–2938.   PubMed Google Scholar
First citationAgirre, J., Atanasova, M., Bagdonas, H., Ballard, C. B., Baslé, A., Beilsten-Edmands, J., Borges, R. J., Brown, D. G., Burgos-Mármol, J. J., Berrisford, J. M., Bond, P. S., Caballero, I., Catapano, L., Chojnowski, G., Cook, A. G., Cowtan, K. D., Croll, T. I., Debreczeni, J. É., Devenish, N. E., Dodson, E. J., Drevon, T. R., Emsley, P., Evans, G., Evans, P. R., Fando, M., Foadi, J., Fuentes-Montero, L., Garman, E. F., Gerstel, M., Gildea, R. J., Hatti, K., Hekkelman, M. L., Heuser, P., Hoh, S. W., Hough, M. A., Jenkins, H. T., Jiménez, E., Joosten, R. P., Keegan, R. M., Keep, N., Krissinel, E. B., Kolenko, P., Kovalevskiy, O., Lamzin, V. S., Lawson, D. M., Lebedev, A. A., Leslie, A. G. W., Lohkamp, B., Long, F., Malý, M., McCoy, A. J., McNicholas, S. J., Medina, A., Millán, C., Murray, J. W., Murshudov, G. N., Nicholls, R. A., Noble, M. E. M., Oeffner, R., Pannu, N. S., Parkhurst, J. M., Pearce, N., Pereira, J., Perrakis, A., Powell, H. R., Read, R. J., Rigden, D. J., Rochira, W., Sammito, M., Sánchez Rodríguez, F., Sheldrick, G. M., Shelley, K. L., Simkovic, F., Simpkin, A. J., Skubak, P., Sobolev, E., Steiner, R. A., Stevenson, K., Tews, I., Thomas, J. M. H., Thorn, A., Valls, J. T., Uski, V., Usón, I., Vagin, A., Velankar, S., Vollmar, M., Walden, H., Waterman, D., Wilson, K. S., Winn, M. D., Winter, G., Wojdyr, M. & Yamashita, K. (2023). Acta Cryst. D79, 449–461.  Web of Science CrossRef IUCr Journals Google Scholar
First citationAragão, D., Aishima, J., Cherukuvada, H., Clarken, R., Clift, M., Cowieson, N. P., Ericsson, D. J., Gee, C. L., Macedo, S., Mudie, N., Panjikar, S., Price, J. R., Riboldi-Tunnicliffe, A., Rostan, R., Williamson, R. & Caradoc-Davies, T. T. (2018). J. Synchrotron Rad. 25, 885–891.  Web of Science CrossRef IUCr Journals Google Scholar
First citationArtz, J. D., Wernimont, A. K., Dunford, J. E., Schapira, M., Dong, A., Zhao, Y., Lew, J., Russell, R. G., Ebetino, F. H., Oppermann, U. & Hui, R. (2011). J. Biol. Chem. 286, 3315–3322.  Web of Science CrossRef CAS PubMed Google Scholar
First citationBricogne, G., Blanc, E., Brandl, M., Flensburg, C., Keller, P., Paciorek, W., Roversi, P, Sharff, A., Smart, O. S., Vonrhein, C. & Womack, T. O. (2017). BUSTER version 2.10.0. Cambridge: Global Phasing Ltd.  Google Scholar
First citationChang, C.-K., Teng, K.-H., Lin, S.-W., Chang, T.-H. & Liang, P.-H. (2013). Biochemistry, 52, 2783–2792.  PubMed Google Scholar
First citationChang, H.-Y., Cheng, T.-H. & Wang, A. H.-J. (2021). IUBMB Life, 73, 40–63.  PubMed Google Scholar
First citationChristianson, D. W. (2017). Chem. Rev. 117, 11570–11648.  Web of Science CrossRef CAS PubMed Google Scholar
First citationDhiman, R. K., Schulbach, M. C., Mahapatra, S., Baulard, A. R., Vissa, V., Brennan, P. J. & Crick, D. C. (2004). J. Lipid Res. 45, 1140–1147.  PubMed Google Scholar
First citationEmsley, P. & Cowtan, K. (2004). Acta Cryst. D60, 2126–2132.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationEmsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. (2010). Acta Cryst. D66, 486–501.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationEvans, P. (2006). Acta Cryst. D62, 72–82.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationEvans, P. R. & Murshudov, G. N. (2013). Acta Cryst. D69, 1204–1214.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationFeng, Y., Morgan, R. M. L., Fraser, P. D., Hellgardt, K. & Nixon, P. J. (2020). Front. Plant Sci. 11, 589.  PubMed Google Scholar
First citationGorrec, F. (2009). J. Appl. Cryst. 42, 1035–1042.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationGuo, R.-T., Cao, R., Liang, P.-H., Ko, T.-P., Chang, T.-H., Hudock, M. P., Jeng, W.-Y., Chen, C. K.-M., Zhang, Y., Song, Y., Kuo, C.-J., Yin, F., Oldfield, E. & Wang, A. H.-J. (2007). Proc. Natl Acad. Sci. USA, 104, 10022–10027.  Web of Science CrossRef PubMed Google Scholar
First citationKabsch, W. (2010a). Acta Cryst. D66, 125–132.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationKabsch, W. (2010b). Acta Cryst. D66, 133–144.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationKantardjieff, K. A. & Rupp, B. (2003). Protein Sci. 12, 1865–1871.  Web of Science CrossRef PubMed CAS Google Scholar
First citationKarplus, P. A. & Diederichs, K. (2015). Curr. Opin. Struct. Biol. 34, 60–68.  Web of Science CrossRef CAS PubMed Google Scholar
First citationKavanagh, K. L., Dunford, J. E., Bunkoczi, G., Russell, R. G. G. & Oppermann, U. (2006). J. Biol. Chem. 281, 22004–22012.  PubMed Google Scholar
First citationKavanagh, K. L., Guo, K., Dunford, J. E., Wu, X., Knapp, S., Ebetino, F. H., Rogers, M. J., Russell, R. G. & Oppermann, U. (2006). Proc. Natl Acad. Sci. USA, 103, 7829–7834.  Web of Science CrossRef PubMed CAS Google Scholar
First citationKeegan, R. M., Long, F., Fazio, V. J., Winn, M. D., Murshudov, G. N. & Vagin, A. A. (2011). Acta Cryst. D67, 313–323.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationKrissinel, E. & Henrick, K. (2004). Acta Cryst. D60, 2256–2268.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationKrissinel, E. & Henrick, K. (2007). J. Mol. Biol. 372, 774–797.  Web of Science CrossRef PubMed CAS Google Scholar
First citationLebedev, A. A. & Isupov, M. N. (2014). Acta Cryst. D70, 2430–2443.  Web of Science CrossRef IUCr Journals Google Scholar
First citationLiang, P. H. (2009). Biochemistry, 48, 6562–6570.  PubMed Google Scholar
First citationLiebschner, D., Afonine, P. V., Baker, M. L., Bunkóczi, G., Chen, V. B., Croll, T. I., Hintze, B., Hung, L.-W., Jain, S., McCoy, A. J., Moriarty, N. W., Oeffner, R. D., Poon, B. K., Prisant, M. G., Read, R. J., Richardson, J. S., Richardson, D. C., Sammito, M. D., Sobolev, O. V., Stockwell, D. H., Terwilliger, T. C., Urzhumtsev, A. G., Videau, L. L., Williams, C. J. & Adams, P. D. (2019). Acta Cryst. D75, 861–877.  Web of Science CrossRef IUCr Journals Google Scholar
First citationLong, F., Vagin, A. A., Young, P. & Murshudov, G. N. (2008). Acta Cryst. D64, 125–132.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationMadeira, F., Madhusoodanan, N., Lee, J., Eusebi, A., Niewielska, A., Tivey, A. R. N., Lopez, R. & Butcher, S. (2024). Nucleic Acids Res. 52, W521–W525.  PubMed Google Scholar
First citationMann, F. M., Thomas, J. A. & Peters, R. J. (2011). FEBS Lett. 585, 549–554.  PubMed Google Scholar
First citationMann, F. M., Xu, M., Davenport, E. K. & Peters, R. J. (2012). Front. Microbiol. 3, 368.  PubMed Google Scholar
First citationMatthews, B. W. (1968). J. Mol. Biol. 33, 491–497.  CrossRef CAS PubMed Web of Science Google Scholar
First citationMcCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C. & Read, R. J. (2007). J. Appl. Cryst. 40, 658–674.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationMeyer, G. R., Aragão, D., Mudie, N. J., Caradoc-Davies, T. T., McGowan, S., Bertling, P. J., Groenewegen, D., Quenette, S. M., Bond, C. S., Buckle, A. M. & Androulakis, S. (2014). Acta Cryst. D70, 2510–2519.  Web of Science CrossRef IUCr Journals Google Scholar
First citationMishra, A. K., Driessen, N. N., Appelmelk, B. J. & Besra, G. S. (2011). FEMS Microbiol. Rev. 35, 1126–1157.  Web of Science CrossRef CAS PubMed Google Scholar
First citationMoreland, N., Ashton, R., Baker, H. M., Ivanovic, I., Patterson, S., Arcus, V. L., Baker, E. N. & Lott, J. S. (2005). Acta Cryst. D61, 1378–1385.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationNagel, R., Thomas, J. A., Adekunle, F. A., Mann, F. M. & Peters, R. J. (2018). Molecules, 23, 2546.  PubMed Google Scholar
First citationOhnuma, S., Narita, K., Nakazawa, T., Ishida, C., Takeuchi, Y., Ohto, C. & Nishino, T. (1996). J. Biol. Chem. 271, 30748–30754.  CrossRef CAS PubMed Web of Science Google Scholar
First citationPark, J., Lin, Y. S., De Schutter, J. W., Tsantrizos, Y. S. & Berghuis, A. M. (2012). BMC Struct. Biol. 12, 32.  Google Scholar
First citationPark, J., Zielinski, M., Magder, A., Tsantrizos, Y. S. & Berghuis, A. M. (2017). Nat. Commun. 8, 14132.  PubMed Google Scholar
First citationRobert, X. & Gouet, P. (2014). Nucleic Acids Res. 42, W320–W324.  Web of Science CrossRef CAS PubMed Google Scholar
First citationStudier, F. W. (2005). Protein Expr. Purif. 41, 207–234.  Web of Science CrossRef PubMed CAS Google Scholar
First citationSun, H.-Y., Ko, T.-P., Kuo, C.-J., Guo, R.-T., Chou, C.-C., Liang, P.-H. & Wang, A. H.-J. (2005). J. Bacteriol. 187, 8137–8148.  PubMed Google Scholar
First citationVagin, A. A., Steiner, R. A., Lebedev, A. A., Potterton, L., Mc­Nicholas, S., Long, F. & Murshudov, G. N. (2004). Acta Cryst. D60, 2184–2195.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationWang, K. C. & Ohnuma, S. (2000). Biochim. Biophys. Acta, 1529, 33–48.  PubMed Google Scholar

This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.

Journal logoSTRUCTURAL BIOLOGY
COMMUNICATIONS
ISSN: 2053-230X
Follow Acta Cryst. F
Sign up for e-alerts
Follow Acta Cryst. on Twitter
Follow us on facebook
Sign up for RSS feeds